These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24195245)

  • 1. [Biomarkers of the Alzheimer's disease: concepts and clinical case].
    Bier JC
    Rev Med Brux; 2013 Sep; 34(4):306-10. PubMed ID: 24195245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New clinical criteria for the Alzheimer's disease spectrum.
    Petersen RC
    Minn Med; 2012 Jan; 95(1):42-5. PubMed ID: 22355912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.
    Ivanoiu A; Dricot L; Gilis N; Grandin C; Lhommel R; Quenon L; Hanseeuw B
    J Alzheimers Dis; 2015; 43(3):835-47. PubMed ID: 25114071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological markers as outcome measures for Alzheimer's disease interventions--real problems and future possibilities.
    Takeda M; Okochi M; Tagami S; Tanaka T; Kudo T
    Int Psychogeriatr; 2007 Jun; 19(3):391-400. PubMed ID: 17391572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
    Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and treatment for Alzheimer's disease: predicting population-level outcomes.
    Furiak NM; Kahle-Wrobleski K; Callahan C; Klein TM; Klein RW; Siemers ER
    Alzheimers Dement; 2012 Jan; 8(1):31-8. PubMed ID: 22265589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    Tromp K; Smedinga M; Richard E; Perry M; Schermer MHN
    J Alzheimers Dis; 2021; 79(2):917-927. PubMed ID: 33361592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing Alzheimer's disease: update for the primary care clinician.
    Mendiratta P; Wei JY
    J Ark Med Soc; 2014 Jan; 110(8):160-3. PubMed ID: 24511859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer's disease: a BeDeCo survey.
    Bier JC; Verschraegen J; Vandenberghe R; Guillaume B; Picard G; Otte G; Mormont E; Gilles C; Segers K; Sieben A; Thiery E; Ventura M; De Deyn P; Deryck O; Versijpt J; Salmon E; Engelborghs S; Ivanoiu A
    Acta Neurol Belg; 2015 Dec; 115(4):547-55. PubMed ID: 25576445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in the diagnosis of Alzheimer's disease: are we ready?
    Sunderland T; Hampel H; Takeda M; Putnam KT; Cohen RM
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):172-9. PubMed ID: 16880359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist.
    Budson AE; Solomon PR
    Pract Neurol; 2012 Apr; 12(2):88-96. PubMed ID: 22450454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
    Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
    Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.